CanniMed Therapeutics Inc. (TSE:CMED – Get Free Report) traded down 5.3% on Monday . The company traded as low as C$27.00 and last traded at C$27.00. 52,208 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 387,394 shares. The stock had previously closed at C$28.50.
CanniMed Therapeutics Stock Performance
The firm has a 50 day simple moving average of C$27.00.
CanniMed Therapeutics Company Profile
CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.
Featured Articles
- Five stocks we like better than CanniMed Therapeutics
- What is the Australian Securities Exchange (ASX)
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- How to Invest in Blue Chip Stocks
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- What is Forex and How Does it Work?
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.